![Adeana Dorsey](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Adeana Dorsey
Plus aucun poste en cours
Profil
Adeana Dorsey is Vice President-Regulatory Affairs at TuHURA Biosciences, Inc. since 2024.
Former positions include Vice President-Regulatory Affairs at Akouos, Inc. in 2022, Director-Regulatory & Strategy Development at Clinipace, Inc. from 2019 to 2022, and Director-Chemistry, Manufacturing & Controls at Cardinal Health, Inc. from 2015 to 2018.
Education includes undergraduate studies at Marshall University.
Postes actifs de Adeana Dorsey
| Sociétés | Poste | Début |
|---|
Anciens postes connus de Adeana Dorsey
| Sociétés | Poste | Fin |
|---|---|---|
| AKOUOS | Conseiller Juridique Général | 01/11/2022 |
Clinipace, Inc.
 Clinipace, Inc. Miscellaneous Commercial ServicesCommercial Services Provides digital contract research solutions | Corporate Officer/Principal | 01/06/2022 |
| CARDINAL HEALTH, INC. | Corporate Officer/Principal | 01/12/2018 |
Formation de Adeana Dorsey
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
24
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Cardinal Health, Inc.
 Cardinal Health, Inc. Medical DistributorsDistribution Services Distributes pharmaceuticals and engages in manufacturing & sale of medical, surgical and laboratory supplies | Distribution Services |
Clinipace, Inc.
Clinipace, Inc. Miscellaneous Commercial ServicesCommercial Services Provides digital contract research solutions | Commercial Services |
Marshall University
 Marshall University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Akouos, Inc.
 Akouos, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a genetic medicine company that develops adeno-associated viral vector-based gene therapies for sensorineural hearing loss | Commercial Services |
